Review of outbreaks and barriers to MMR vaccination coverage among hard to reach populations in European countries
In recent years, substantial progress had been made towards eliminating measles, mumps and rubella in Europe. Measles vaccine coverage is on the rise and measles cases decreasing in many countries. However, there have still been several large outbreaks of measles, mumps and rubella reported in European countries.
Conducting health communication activities on MMR vaccination
This guide presents the reader with a host of ideas on how to effectively communicate on all issues that relate to measles, mumps and rubella (MMR) vaccination.
Systematic review on the incubation and infectiousness/shedding period of communicable diseases in children
Illnesses caused by infectious diseases are common in children in schools or other childcare settings. Currently there is no common EU approach to the control of communicable diseases in schools or other childcare settings, and existing information is uncertain.
Seroprevalence of Measles-, Mumps- and Rubella-Specific IgG Antibodies in German Children and Adolescents and Predictors for SeronegativityArchived
This large population based sero-epidemiological study describes MMR seroprevalence as a whole and calculates independent predictors for seronegativity for measles, mumps and rubella antibodies in Germany.
A collaborative approach to investigating the risk of thrombocytopenic purpura after measles-mumps-rubella vaccination in England and Denmark
rews, N., Stowe, J., Miller, E., Svanstrom, H., Johansen, K., Bonhoeffer, J., Hviid, A., VAESCO Consortium